date,title,source
Oct-23-18,Five Prime Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on November 6,Business Wire
Nov-01-18,"Big pharma leases almost 500,000 square feet for new research center",American City Business Journals
Nov-05-18,Five Prime Therapeutics Announces David V. Smith Will Join as Chief Financial Officer,Business Wire
Nov-06-18,"Five Prime Therapeutics (FPRX) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-06-18,Five Prime Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Five Prime Therapeutics Announces Third Quarter 2018 Financial Results,Business Wire
Nov-07-18,Edited Transcript of FPRX earnings conference call or presentation 6-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-08-18,Edited Transcript of FPRX earnings conference call or presentation 6-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-09-18,"New Research Coverage Highlights American Public Education, Protagonist Therapeutics, TravelCenters of America, Five Prime Therapeutics, Red Robin Gourmet Burgers, and Hemisphere Media Group  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-12-18,"Health Care Digest: A big Berkeley bio incubator, Apple's clinical trial help and more",American City Business Journals
Nov-14-18,"Five Prime Therapeutics Initiates Patient Dosing in a Phase 1 Clinical Trial of FPT155, a First-in-Class CD80 Fusion Protein",Business Wire
Nov-20-18,Five Prime Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference,Business Wire
Nov-20-18,Edited Transcript of FPRX earnings conference call or presentation 6-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,3 Top Biotech Stocks to Buy Right Now,Motley Fool
Nov-29-18,Five Prime Therapeutics Announces Changes to its Board of Directors,Business Wire
Dec-12-18,Five Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,Business Wire
Jan-14-19,Five Prime Therapeutics Announces Two Poster Presentations at the 2019 Gastrointestinal Cancers Symposium,Business Wire
Jan-15-19,Peninsula biotech sheds 20% of jobs to focus on drugs closer to finish line,American City Business Journals
Jan-15-19,Five Prime Announces Restructuring to Focus on Clinical Development and Later-Stage Research Priorities,Business Wire
Jan-16-19,"Consolidated Research: 2019 Summary Expectations for Southern, Exelon, PriceSmart, Five Prime Therapeutics, Digi International, and Voyager Therapeutics  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Jan-17-19,Five Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium,Business Wire
Jan-24-19,"Five Prime Therapeutics, Inc. (FPRX) Shares March Higher, Can It Continue?",Zacks
Jan-28-19,MacroGenics Up on Lifting of Partial Hold on Cancer Candidate,Zacks
Feb-04-19,Five Prime Therapeutics to Present at the Guggenheim Healthcare Talks Idea Forum,Business Wire
Feb-07-19,Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26,Business Wire
Feb-20-19,Five Prime Therapeutics Doses First Patient in Phase 1b Trial of FPA150,Business Wire
Feb-26-19,Five Prime Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results,Business Wire
Feb-27-19,Edited Transcript of FPRX earnings conference call or presentation 26-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-01-19,Edited Transcript of FPRX earnings conference call or presentation 26-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
Mar-05-19,Five Prime Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference,Business Wire
Mar-07-19,Edited Transcript of FPRX earnings conference call or presentation 26-Feb-19 9:30pm GMT,Thomson Reuters StreetEvents
